Shusterman, S., Naranjo, A., Van Ryn, C., Hank, J. A., Parisi, M. T., Shulkin, B. L., . . . Sondel, P. M. (2019). Anti-tumor activity and tolerability of hu14.18-IL2 with GMCSF and isotretinoin in recurrent or refractory neuroblastoma: A Children’s Oncology Group phase II study. Clin Cancer Res.
Citação norma ChicagoShusterman, Suzanne, et al. "Anti-tumor Activity and Tolerability of Hu14.18-IL2 With GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children’s Oncology Group Phase II Study." Clin Cancer Res 2019.
ציטוט MLAShusterman, Suzanne, et al. "Anti-tumor Activity and Tolerability of Hu14.18-IL2 With GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children’s Oncology Group Phase II Study." Clin Cancer Res 2019.